In contrast, RIN1 expression levels were reported to be elevated in various tumors, including gastric adenocarcinoma [19], colorectal cancer [17], non-small cell lung cancer [12], and bladder urothelial carcinoma [20]. Here, RIN1 is linked to bladder transitional cell carcinoma.